Literature DB >> 26926124

A New Option for Treating Bipolar I Depression.

Holly A Swartz1, Joseph T Tasosa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26926124      PMCID： PMC5082108          DOI： 10.1176/appi.ajp.2015.15111409

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  10 in total

Review 1.  Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.

Authors:  Michelle M Sidor; Glenda M Macqueen
Journal:  J Clin Psychiatry       Date:  2010-10-05       Impact factor: 4.384

2.  Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.

Authors:  Joseph R Calabrese; Paul E Keck; Anju Starace; Kaifeng Lu; Adam Ruth; István Laszlovszky; György Németh; Suresh Durgam
Journal:  J Clin Psychiatry       Date:  2015-03       Impact factor: 4.384

3.  The long-term natural history of the weekly symptomatic status of bipolar I disorder.

Authors:  Lewis L Judd; Hagop S Akiskal; Pamela J Schettler; Jean Endicott; Jack Maser; David A Solomon; Andrew C Leon; John A Rice; Martin B Keller
Journal:  Arch Gen Psychiatry       Date:  2002-06

4.  Bipolar depression: an underestimated treatment challenge.

Authors:  S A Hlastala; E Frank; A G Mallinger; M E Thase; A M Ritenour; D J Kupfer
Journal:  Depress Anxiety       Date:  1997       Impact factor: 6.505

5.  Clinical and therapeutic implications of predominant polarity in bipolar disorder.

Authors:  F Colom; E Vieta; C Daban; I Pacchiarotti; J Sánchez-Moreno
Journal:  J Affect Disord       Date:  2006-05-02       Impact factor: 4.839

6.  Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.

Authors:  Michael E Thase; Alan Jonas; Arif Khan; Charles L Bowden; Xiaoling Wu; Robert D McQuade; William H Carson; Ronald N Marcus; Randall Owen
Journal:  J Clin Psychopharmacol       Date:  2008-02       Impact factor: 3.153

7.  Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness.

Authors:  M B Keller; P W Lavori; W Coryell; N C Andreasen; J Endicott; P J Clayton; G L Klerman; R M Hirschfeld
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

Review 8.  Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.

Authors:  D M Taylor; V Cornelius; L Smith; A H Young
Journal:  Acta Psychiatr Scand       Date:  2014-10-06       Impact factor: 6.392

9.  An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression.

Authors:  Suresh Durgam; Willie Earley; Alan Lipschitz; Hua Guo; István Laszlovszky; György Németh; Eduard Vieta; Joseph R Calabrese; Lakshmi N Yatham
Journal:  Am J Psychiatry       Date:  2015-11-06       Impact factor: 18.112

10.  Relapse and impairment in bipolar disorder.

Authors:  M J Gitlin; J Swendsen; T L Heller; C Hammen
Journal:  Am J Psychiatry       Date:  1995-11       Impact factor: 18.112
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.